AKISHA WILSON: Open Payments
NPI 1861860611 · BRENTWOOD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 48 payments from 17 companies in 2025. Trend: 2023 $253 · 2024 $155 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $165 |
| Alkermes, Inc. | 7 | $142 |
| Teva Pharmaceuticals USA, Inc. | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Neos Therapeutics, LP | 2 | $64 |
| Luye Pharma (USA) Ltd. | 2 | $51 |
| Dexcom, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $44 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Auvelity, AUSTEDO XR, EXXUA, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE.
Industry payments across NY — which companies pay providers there.
